SSH -MEMPHIS INC — History
CCN 442014 | 3-year financial timeline | COVID resilience: 23/100
🛡️ Public data only — no PHI permitted on this instance.
$21M
Latest Revenue (FY2022)
-7.4%
Revenue CAGR (3yr)
-4.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $24M | $24M | $21M | -13.7% | -7.4% |
| Operating Expenses | $22M | $21M | $22M | +0.6% | +0.0% |
| Operating Margin | 10.8% | 10.8% | -4.0% | -137.0% | +0.0% |
| Net Income | $3M | $3M | $-1M | -131.9% | +0.0% |
| Licensed Beds | 39 | 39 | 39 | +0.0% | +0.0% |
| Total Patient Days | 12,055 | 11,457 | 10,103 | -11.8% | -8.5% |
| Medicare Day % | 45% | 39% | 42% | +5.9% | -4.2% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 23/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -14.2% ($24M → $21M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-7.4%
This Hospital
+7.6%
State Avg
Latest Margin
-4.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $19M | -11.4% |
| FY2024 (proj) | $17M | -18.8% |
| FY2025 (proj) | $16M | -26.2% |